Syntheses and structure-activity relationship studies of piperidine-substituted quinolones as nonpeptide gonadotropin releasing hormone antagonists

被引:21
|
作者
Jiang, JL
DeVita, RJ
Goulet, MT
Wyvratt, WJ
Lo, JL
Ren, N
Yudkovitz, JB
Cui, JS
Yang, YT
Cheng, K
Rohrer, SP
机构
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Atherosclerosis & Endocrinol, Rahway, NJ 07065 USA
关键词
D O I
10.1016/j.bmcl.2003.12.101
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Syntheses and structure-activity relationships of piperidine-substituted quinolones as nonpeptide gonadotropin releasing hormone antagonists are described. Some of substituents on the piperidine ring that were investigated included a fused phenyl group, a (6R)-trifluoromethyl group, (6S) and (6R)-methyl group. This study showed that GnRH binding potency was tolerated by a small group at the 6-position of the piperidine, and blocking the 6-position by a trifluoromethyl group reduced clearance rate and increased oral bioavailability. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1795 / 1798
页数:4
相关论文
共 50 条
  • [1] Structure-activity relationship studies of gonadotropin-releasing hormone antagonists containing S-aryl/alkyl norcysteines and their oxidized derivatives
    Samant, Manoj P.
    White, Richard
    Hong, Doley J.
    Croston, Glenn
    Conn, P. Michael
    Janovick, Jo Ann
    Rivier, Jean
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (09) : 2067 - 2077
  • [2] Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: Implications for structure-activity relationships and insurmountable antagonism
    Sullivan, Susan K.
    Hoare, Sam R. J.
    Fleck, Beth A.
    Zhu, Yun-Fei
    Heise, Christopher E.
    Struthers, R. Scott
    Crowe, Paul D.
    BIOCHEMICAL PHARMACOLOGY, 2006, 72 (07) : 838 - 849
  • [3] STRUCTURE-ACTIVITY STUDIES OF ANTAGONISTS OF LUTEINIZING-HORMONE-RELEASING HORMONE WITH EMPHASIS ON THE AMINO-TERMINAL REGION
    HOCART, SJ
    NEKOLA, MV
    COY, DH
    JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (04) : 735 - 739
  • [4] NOVEL PARATHYROID-HORMONE RECEPTOR ANTAGONISTS - METHODOLOGICAL AND STRUCTURE-ACTIVITY RELATIONSHIP STUDIES
    GOLDMAN, ME
    CHOREV, M
    MCKEE, RL
    NUTT, RF
    CAULFIELD, MP
    ROSENBLATT, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1988, 196 : 115 - AGRO
  • [5] Structure-activity relationship studies on tetralin carboxamide growth hormone secretagogue receptor antagonists
    Zhao, HY
    Xi, ZL
    Patel, JR
    Nelson, LTJ
    Liu, B
    Szczepankiewicz, BG
    Schaefer, VG
    Falls, HD
    Kaszubska, W
    Collins, CA
    Sham, HL
    Liu, G
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (07) : 1825 - 1828
  • [6] PHARMACOLOGICAL STUDIES ON STRUCTURE-ACTIVITY RELATIONSHIP OF MORPHINE ANTAGONISTS
    ANAND, DR
    ARZNEIMITTEL-FORSCHUNG, 1965, 15 (05): : 564 - &
  • [7] Quantitative structure-activity relationship studies on cholecystokinin antagonists
    Gupta, SP
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (02) : 111 - 124
  • [8] Structure-activity studies on 4-substituted-2-anilinopyrimidine corticotropin releasing factor (CRF) antagonists
    Gilligan, PJ
    He, LQ
    Culp, S
    Fitzgerald, L
    Tam, SW
    Wong, YN
    BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (11) : 2321 - 2328
  • [9] CHEMISTRY OF HYPOTHALAMIC NEUROHORMONES - SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIP STUDIES OF THYROTROPIN-RELEASING HORMONE AND LUTEINIZING-HORMONE-RELEASING HORMONE
    SIEVERTSSON, H
    ACTA PHARMACEUTICA SUECICA, 1972, 9 (01): : 19 - +
  • [10] ANTI-MYCOBACTERIUM-AVIUM ACTIVITY OF QUINOLONES - STRUCTURE-ACTIVITY RELATIONSHIP STUDIES
    KLOPMAN, G
    WANG, SM
    JACOBS, MR
    ELLNER, JJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (09) : 1807 - 1815